Veterinary, IT and Other Life Sciences Markets

We have developed, managed and consulted with a number of veterinary, information technology and related companies, and know what kind of issues they face in capitalizing on their technology assets and market approaches.  We have helped them acquire, develop and successfully introduce new products— as well as acquire and sell entire businesses and companies.   The dynamics are unique to each market, and it takes special expertise to understand the technical and market nuances quickly in order to fully capitalize on the opportunity in the face of stiff competition.

To help you capitalize on your opportunities, TCG brings its extensive operational and executive experience with all the functions and complexities of companies like Embrex (now part of Pfizer Animal Health), WebSurg and Vet Insite ….large and small firms just like yours. For virtually any market niche or product, we quickly grasp the value of the opportunity in context with the specific forces that will shape your potential. Then we translate that potential into reality.

We can help you with:

• Distribution Channels & Strategic Partners
• US subsidiaries of Foreign Companies
• Technology licensing: R&D Partnerships and Commercialization
• Market Research
• Operational Assessments & Strategic Planning
• Regulatory Affairs and Patent Management

When partnering with European companies, you must be aware of the cultural differences. An interview with Dr. Bob. Keefer, originally published in the Triangle Tech Journal, gives valuable hints.

"Commercialization is all part of brand management, how you build a brand. The companies who specialize in this may prove very helpful" says Dr. Robert Keefer. Read Companies Supporting Other Companies from The State of Life Sciences in North Carolina (Supplement) in The Scientist. To view the full article, click on The Scientist, April 2007.